Jiangbo Wang

age ~51

from Chapel Hill, NC

Also known as:
  • Bo Wang Jiang
Phone and address:
105 Big Meadows Pl, Chapel Hill, NC 27514

Jiangbo Wang Phones & Addresses

  • 105 Big Meadows Pl, Chapel Hill, NC 27514
  • Davenport, FL
  • Durham, NC
  • 16003 Bowman Dr, Lewes, DE 19958 • 3026443576
  • 921 Bowman Dr, Lewes, DE 19958 • 3026443576
  • 7 Woodhill Ct, Durham, NC 27713

Work

  • Position:
    Student

Us Patents

  • Smoothened Receptor Modulators

    view source
  • US Patent:
    20120094974, Apr 19, 2012
  • Filed:
    Jun 16, 2009
  • Appl. No.:
    12/737044
  • Inventors:
    Wei Chen - Durham NC, US
    Lawrence Barak - Durham NC, US
    H. Kim Lyerly - Durham NC, US
    Jiangbo Wang - Durham NC, US
  • International Classification:
    A61K 31/454
    A61K 31/5377
    A61K 31/55
    A61K 31/553
    A61P 35/00
    A61K 31/551
    A61K 31/4545
    A61K 31/426
    A61K 31/4439
    A61K 31/538
    A61K 31/506
    A61K 31/4725
  • US Classification:
    51421021, 51425218, 51425214, 5142355, 514318, 51421704, 51421115, 514307, 514218, 514365, 514342, 5142305
  • Abstract:
    The present invention relates, in general, to the Smoothened receptor and, in particular, to a method of modulating Smoothened receptor activity and to compounds and compositions suitable for use in such a method.
  • Radiolabled Cyclopamine Assay For The Smoothened Receptor

    view source
  • US Patent:
    20110236907, Sep 29, 2011
  • Filed:
    Jun 16, 2009
  • Appl. No.:
    12/999922
  • Inventors:
    Wei Chen - Chapel Hill NC, US
    Lawrence S. Barak - Durham NC, US
    Jiangbo Wang - Durham NC, US
    Robert J. Lefkowitz - Durham NC, US
    Herbert Kim Lyerly - Chapel Hill NC, US
  • International Classification:
    G01N 23/00
  • US Classification:
    435 72
  • Abstract:
    The present invention discloses novel methods for screening compositions for both agonist and antagonist activity on the smoothened receptor. The assay tests ligands on the activity of the receptor using a cyclopamine binding and ultra high receptor expression.
  • Chemical Modulators Of Signaling Pathways And Therapeutic Use

    view source
  • US Patent:
    20200038350, Feb 6, 2020
  • Filed:
    Jun 24, 2016
  • Appl. No.:
    15/739390
  • Inventors:
    - Durham NC, US
    Jiangbo Wang - Durham NC, US
    Minyong Chen - Durham NC, US
    Lawrence S. Barak - Durham NC, US
    Herbert Kim Lyerly - Chapel Hill NC, US
    David Needham - Durham NC, US
  • International Classification:
    A61K 31/167
    A61K 9/00
    A61P 35/00
    A61P 1/16
    A61K 31/4188
    A61K 31/5375
    A61K 31/47
    A61K 31/18
    A61K 31/196
    A61K 31/4015
    A61K 31/536
  • Abstract:
    Described are methods of treating a disease associated with dysregulation of the Wnt/Frizzled signaling pathway. The methods include identifying subjects in need of therapy, administering inhibitors of the Wnt/Frizzled signaling pathway, pharmaceutical compositions including the inhibitors, and methods of using the compounds and compositions for treating cancer, bacterial and viral infection, lupus, type II diabetes, nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD) in a subject.
  • Niclosamide-Conjugated Polypeptide Nanoparticles

    view source
  • US Patent:
    20190083638, Mar 21, 2019
  • Filed:
    Jul 25, 2018
  • Appl. No.:
    16/045556
  • Inventors:
    - Durham NC, US
    Jayanta Bhattacharyya - Durham NC, US
    Robert A. Mook - Chapel Hill NC, US
    Jiangbo Wang - Durham NC, US
    Ivan Spasojevic - Durham NC, US
    Richard Premont - Durham NC, US
    Xinghai Li - Durham NC, US
    Ashutosh Chilkoti - Durham NC, US
  • International Classification:
    A61K 47/64
    A61K 31/167
    A61P 35/00
    A61P 19/02
    A61P 3/08
    A61K 47/69
  • Abstract:
    Disclosed herein are conjugates of a therapeutic compound and polypeptides, such as a conjugate of niclosamide and an elastin-like polypeptide. These conjugates may form nanoparticles through self-assembly, which improve the solubility, bioavailability, and pharmacokinetic profiles of the therapeutic compound. Also disclosed are methods for treating cancer, parasite infection, bacterial infection, viral infection, metabolic diseases, Type II diabetes, NASH, NAFLD, artery constriction, endometriosis, neuropathic pain, rheumatoid arthritis, sclerodermatous graft-versus-host disease, and systemic sclerosis.
  • Chemical Modulators Of Immune Checkpoints And Therapeutic Use

    view source
  • US Patent:
    20190077772, Mar 14, 2019
  • Filed:
    Nov 14, 2018
  • Appl. No.:
    16/191243
  • Inventors:
    - Durham NC, US
    Herbert Kim Lyerly - Chapel Hill NC, US
    Jiangbo Wang - Durham NC, US
    Hongtao Guo - Durham NC, US
    Amy Hobeika - Durham NC, US
    Robert A. Mook - Chapel Hill NC, US
  • International Classification:
    C07D 249/08
    A61K 45/06
    A61K 31/4184
    C07D 235/18
    A61K 31/4196
  • Abstract:
    Compounds and pharmaceutical compositions that down-regulate immune checkpoints such as PD-1, PD-L1 and CTLA-4 are provided. Also provided are methods of treating a disease by down-regulating immune checkpoints such as PD-1, PD-L1 and CTLA-4. The methods are useful for treating cancer and viral infection in a subject.
  • New Methods Of Use For An Anti-Diarrhea Agent

    view source
  • US Patent:
    20190070154, Mar 7, 2019
  • Filed:
    Jun 24, 2016
  • Appl. No.:
    15/739396
  • Inventors:
    - Durham NC, US
    Jiangbo Wang - Durham NC, US
    Minyong Chen - Durham NC, US
    Lawrence S. Barak - Durham NC, US
    Herbert Kim Lyerly - Chapel Hill NC, US
  • International Classification:
    A61K 31/44
    A61K 45/06
    A61K 31/426
    A61K 39/395
    A61K 33/24
    A61K 31/282
  • Abstract:
    Described are methods of treating a disease associated with dysregulation of the Wnt/Frizzled signaling pathway. The methods include identifying subjects in need of therapy, administering inhibitors of the Wnt/Frizzled signaling pathway, pharmaceutical compositions including the inhibitors, and methods of using the compounds and compositions for treating cancer, bacterial Sand viral infection, lupus, type II diabetes, nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD) in a subject.
  • Chemical Modulators Of Immune Checkpoints And Therapeutic Use

    view source
  • US Patent:
    20170190675, Jul 6, 2017
  • Filed:
    Dec 30, 2016
  • Appl. No.:
    15/395464
  • Inventors:
    - Durham NC, US
    Herbert Kim Lyerly - Chapel Hill NC, US
    Jiangbo Wang - Durham NC, US
    Hongtao Guo - Durham NC, US
    Amy Hobeika - Durham NC, US
    Robert A. Mook - Chapel Hill NC, US
  • International Classification:
    C07D 249/08
    A61K 45/06
    A61K 31/4184
    C07D 235/18
    A61K 31/4196
  • Abstract:
    Compounds and pharmaceutical compositions that down-regulate immune checkpoints such as PD-1, PD-L1 and CTLA-4 are provided. Also provided are methods of treating a disease by down-regulating immune checkpoints such as PD-1, PD-L1 and CTLA-4. The methods are useful for treating cancer and viral infection in a subject.
  • Smoothened Modulators And Methods Of Use Thereof

    view source
  • US Patent:
    20150166509, Jun 18, 2015
  • Filed:
    Sep 16, 2013
  • Appl. No.:
    14/405614
  • Inventors:
    - Durham NC, US
    Jiangbo Wang - Durham NC, US
    Lawrence S. Barak - Durham NC, US
    H. Kim Lyerly - Durham NC, US
    Anthony Angelo Ribeiro - Durham NC, US
  • International Classification:
    C07D 401/14
    C12N 5/0793
  • Abstract:
    Compounds of general Formulas (I), (IA), (IB) are described, along with compositions containing the same and methods of use thereof, inhibiting the hedgehog pathway in a cell or inhibiting unwanted proliferation of a cell.

Youtube

"" #ShadowBan

##shado... #shadowban.

  • Duration:
    19m 1s

Jixian Wang

  • Duration:
    18m 59s

Alexander Wang s Video

For school application.

  • Duration:
    4m 57s

Googleplus

Jiangbo Wang Photo 1

Jiangbo Wang

Jiangbo Wang Photo 2

Jiangbo Wang


Get Report for Jiangbo Wang from Chapel Hill, NC, age ~51
Control profile